Streptococcus pyogenescolonization in children aged 24-59 months in The Gambia: Impact of Live Attenuated Influenza Vaccine and associated serological responses

Author:

Keeley Alexander J.ORCID,Groves Danielle,Armitage Edwin P.,Senghore Elina,Jagne Ya Jankey,Sallah Hadijatou J.,Drammeh Sainabou,Angyal Adri,Hornsby Hailey,de Crombrugghe Gabrielle,Smeesters Pierre,Rossi Omar,Carducci Martina,Peno Chikondi,Bogaert Debby,Kampmann Beate,Marks Michael,Shaw Helen A.,Turner Claire E.,de Silva Thushan I.

Abstract

AbstractBackgroundImmunity toStreptococcus pyogenesin high burden settings is poorly understood. We exploredS. pyogenesnasopharyngeal colonization after intranasal live attenuated influenza vaccine (LAIV) among Gambian children aged 24-59 months, and resulting serological response to 7 antigens.MethodsA post-hoc analysis was performed in 320 children randomized to receive LAIV at baseline (LAIV group) or not (control).S. pyogenescolonization was determined by quantitative Polymerase Chain Reaction (qPCR) on nasopharyngeal swabs from baseline (D0), day 7 (D7) and day 21 (D21). Anti-streptococcal IgG was quantified, including a subset with paired serum pre/postS. pyogenesacquisition.ResultsThe point prevalence ofS. pyogenescolonization ranged from 7-13%. In children negative at D0,S. pyogeneswas detected at D7 or D21 in 18% of LAIV group and 11% of control group participants (p=0.12). The odds ratio (OR) for colonization over time was significantly increased in the LAIV group (D21 vs D0 OR 3.18, p=0.003) but not in the control group (OR 0.86, p=0.79). The highest IgG increases following asymptomatic colonization were seen for M1 and SpyCEP proteins.ConclusionsAsymptomaticS. pyogenescolonization appears modestly increased by LAIV, and may be immunologically significant. LAIV could be used to study influenza-S. pyogenesinteractions.

Publisher

Cold Spring Harbor Laboratory

Reference38 articles.

1. The global burden of group A streptococcal diseases

2. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015

3. World Health O. WHO preferred product characteristics for group A streptococcus vaccines. Geneva: World Health Organization, 2018.

4. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3